Cellular Senescence: Aging, Cancer, and Injury
- PMID: 30648461
- DOI: 10.1152/physrev.00020.2018
Cellular Senescence: Aging, Cancer, and Injury
Abstract
Cellular senescence is a permanent state of cell cycle arrest that occurs in proliferating cells subjected to different stresses. Senescence is, therefore, a cellular defense mechanism that prevents the cells to acquire an unnecessary damage. The senescent state is accompanied by a failure to re-enter the cell cycle in response to mitogenic stimuli, an enhanced secretory phenotype and resistance to cell death. Senescence takes place in several tissues during different physiological and pathological processes such as tissue remodeling, injury, cancer, and aging. Although senescence is one of the causative processes of aging and it is responsible of aging-related disorders, senescent cells can also play a positive role. In embryogenesis and tissue remodeling, senescent cells are required for the proper development of the embryo and tissue repair. In cancer, senescence works as a potent barrier to prevent tumorigenesis. Therefore, the identification and characterization of key features of senescence, the induction of senescence in cancer cells, or the elimination of senescent cells by pharmacological interventions in aging tissues is gaining consideration in several fields of research. Here, we describe the known key features of senescence, the cell-autonomous, and noncell-autonomous regulators of senescence, and we attempt to discuss the functional role of this fundamental process in different contexts in light of the development of novel therapeutic targets.
Similar articles
-
Cellular Senescence: What, Why, and How.Wounds. 2017 Jun;29(6):168-174. Wounds. 2017. PMID: 28682291 Review.
-
To clear, or not to clear (senescent cells)? That is the question.Bioessays. 2016 Jul;38 Suppl 1:S56-64. doi: 10.1002/bies.201670910. Bioessays. 2016. PMID: 27417123 Review.
-
The ECM path of senescence in aging: components and modifiers.FEBS J. 2020 Jul;287(13):2636-2646. doi: 10.1111/febs.15282. Epub 2020 Mar 20. FEBS J. 2020. PMID: 32145148 Review.
-
Oncogenic senescence: a multi-functional perspective.Oncotarget. 2017 Apr 18;8(16):27661-27672. doi: 10.18632/oncotarget.15742. Oncotarget. 2017. PMID: 28416761 Free PMC article.
-
Cellular senescence in ageing, age-related disease and longevity.Curr Vasc Pharmacol. 2014;12(5):698-706. doi: 10.2174/1570161111666131219094045. Curr Vasc Pharmacol. 2014. PMID: 24350932 Review.
Cited by
-
Redd1 knockdown prevents doxorubicin-induced cardiac senescence.Aging (Albany NY). 2021 May 6;13(10):13788-13806. doi: 10.18632/aging.202972. Epub 2021 May 6. Aging (Albany NY). 2021. PMID: 33962393 Free PMC article.
-
MiR-96-5p Suppresses Progression of Arsenite-Induced Human Keratinocyte Proliferation and Malignant Transformation by Targeting Denticleless E3 Ubiquitin Protein Ligase Homolog.Toxics. 2023 Dec 1;11(12):978. doi: 10.3390/toxics11120978. Toxics. 2023. PMID: 38133379 Free PMC article.
-
EED-mediated histone methylation is critical for CNS myelination and remyelination by inhibiting WNT, BMP, and senescence pathways.Sci Adv. 2020 Aug 12;6(33):eaaz6477. doi: 10.1126/sciadv.aaz6477. eCollection 2020 Aug. Sci Adv. 2020. PMID: 32851157 Free PMC article.
-
Identification of senescence-related molecular subtypes and key genes for prostate cancer.Asian J Androl. 2023 Mar-Apr;25(2):223-229. doi: 10.4103/aja202258. Asian J Androl. 2023. PMID: 36124532 Free PMC article.
-
Targeting of non-apoptotic cancer cell death mechanisms by quercetin: Implications in cancer therapy.Front Pharmacol. 2022 Nov 16;13:1043056. doi: 10.3389/fphar.2022.1043056. eCollection 2022. Front Pharmacol. 2022. PMID: 36467088 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical